Literature DB >> 11016903

A polymorphism of the 5'-flanking region of the glucocorticoid receptor gene locus is associated with basal cortisol secretion in men.

R Rosmond1, Y C Chagnon, M Chagnon, L Pérusse, C Bouchard, P Björntorp.   

Abstract

There is growing evidence that cortisol secretion and/or metabolism is associated with cardiovascular risk factors. Previous studies have shown that cardiovascular risk factors are associated with stimulated cortisol secretion and not with basal cortisol secretion. With the restriction enzyme Tth111I, a variant of the 5'-flanking region of the glucocorticoid receptor gene locus (GRL) was identified. The genotypes were compared for measurements of cortisol secretion and cardiovascular risk factors in a cohort (N = 284) of randomly selected middle-aged men. The frequency of the 3.4/3.4-, 3.4/3.8-, and 3.8/3.8-kilobase (kb) genotypes was 49.6%, 41.4%, and 9.0% respectively. The 3.8-kb homozygotes showed higher total and evening cortisol levels with a trend for elevated levels over the day. Neither stimulated or suppressed cortisol secretion nor anthropometric, endocrine, metabolic, and hemodynamic cardiovascular risk factors were significantly different among the genotypes. Since the polymorphism studied herein is localized at the 5'-flanking region of the GRL, the results suggest that elevated basal cortisol secretion is associated with a polymorphism of the promoter region.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11016903     DOI: 10.1053/meta.2000.7712

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  18 in total

Review 1.  Corticosteroid receptor genetic polymorphisms and stress responsivity.

Authors:  Roel DeRijk; E Ronald de Kloet
Journal:  Endocrine       Date:  2005-12       Impact factor: 3.633

2.  The NR3C1 Glucocorticoid Receptor Gene Polymorphisms May Modulate the TGF-beta mRNA Expression in Asthma Patients.

Authors:  Michał Panek; Tadeusz Pietras; Artur Fabijan; Jan Zioło; Łukasz Wieteska; Beata Małachowska; Wojciech Fendler; Janusz Szemraj; Piotr Kuna
Journal:  Inflammation       Date:  2015-08       Impact factor: 4.092

3.  Transcriptional control of the human glucocorticoid receptor: identification and analysis of alternative promoter regions.

Authors:  Lei Cao-Lei; Salomon Carlos Leija; Robert Kumsta; Stefan Wüst; Jobst Meyer; Jonathan D Turner; Claude P Muller
Journal:  Hum Genet       Date:  2011-01-15       Impact factor: 4.132

Review 4.  The role of glucocorticoids and progestins in inflammatory, autoimmune, and infectious disease.

Authors:  A Sasha Tait; Cherie L Butts; Esther M Sternberg
Journal:  J Leukoc Biol       Date:  2008-07-29       Impact factor: 4.962

5.  Mifepristone pretreatment reduces ethanol withdrawal severity in vivo.

Authors:  Lynda Sharrett-Field; Tracy R Butler; Jennifer N Berry; Anna R Reynolds; Mark A Prendergast
Journal:  Alcohol Clin Exp Res       Date:  2013-03-25       Impact factor: 3.455

6.  Glucocorticoid receptor gene polymorphisms do not affect growth in fetal and early postnatal life. The Generation R Study.

Authors:  Miranda J J Geelhoed; Eric A P Steegers; Jan W Koper; Elisabeth F C van Rossum; Henriette A Moll; Hein Raat; Henning Tiemeier; Albert Hofman; Vincent W V Jaddoe
Journal:  BMC Med Genet       Date:  2010-03-03       Impact factor: 2.103

Review 7.  Early influences on cardiovascular and renal development.

Authors:  J J Miranda Geelhoed; Vincent W V Jaddoe
Journal:  Eur J Epidemiol       Date:  2010-09-25       Impact factor: 8.082

8.  Hypothalamic-pituitary-adrenal axis function: relative contributions of perceived stress and obesity in women.

Authors:  Noha H Farag; William E Moore; William R Lovallo; Paul J Mills; Srikrishna Khandrika; June E Eichner
Journal:  J Womens Health (Larchmt)       Date:  2008-12       Impact factor: 2.681

9.  Impact of glucocorticoid receptor gene (NR3C1) polymorphisms in Turkish patients with metabolic syndrome.

Authors:  Z Kaya; S Caglayan; M Akkiprik; C Aral; G Ozisik; M Ozata; A Ozer
Journal:  J Endocrinol Invest       Date:  2015-11-23       Impact factor: 4.256

Review 10.  Stress and obesity: the role of the hypothalamic-pituitary-adrenal axis in metabolic disease.

Authors:  Mousumi Bose; Blanca Oliván; Blandine Laferrère
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2009-10       Impact factor: 3.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.